Financhill
Sell
48

ZBRA Quote, Financials, Valuation and Earnings

Last price:
$265.52
Seasonality move :
3.63%
Day range:
$251.86 - $259.84
52-week range:
$205.73 - $427.76
Dividend yield:
0%
P/E ratio:
23.73x
P/S ratio:
2.55x
P/B ratio:
3.52x
Volume:
521.8K
Avg. volume:
735.8K
1-year change:
-19.06%
Market cap:
$12.8B
Revenue:
$5B
EPS (TTM):
$10.57
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $4.4B $5.6B $5.8B $4.6B $5B
Revenue Growth (YoY) -0.83% 26.51% 2.74% -20.71% 8.66%
 
Cost of Revenues $2.4B $3B $3.2B $2.5B $2.6B
Gross Profit $2B $2.6B $2.6B $2.1B $2.4B
Gross Profit Margin 45.03% 46.7% 45.39% 46.31% 48.44%
 
R&D Expenses $453M $567M $570M $519M $563M
Selling, General & Admin $787M $935M $982M $915M $981M
Other Inc / (Exp) -$49M -$38M -$415M -$118M -$32M
Operating Expenses $1.3B $1.6B $1.7B $1.5B $1.6B
Operating Income $685M $1B $936M $585M $765M
 
Net Interest Expenses $76M $5M -- $133M $98M
EBT. Incl. Unusual Items $560M $968M $544M $334M $635M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $56M $131M $81M $38M $107M
Net Income to Company $504M $837M $463M $296M $528M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $504M $837M $463M $296M $528M
 
Basic EPS (Cont. Ops) $9.43 $15.66 $8.86 $5.75 $10.25
Diluted EPS (Cont. Ops) $9.35 $15.52 $8.80 $5.72 $10.18
Weighted Average Basic Share $53.4M $53.4M $52.2M $51.4M $51.5M
Weighted Average Diluted Share $53.9M $53.9M $52.6M $51.7M $51.9M
 
EBITDA $782M $1.2B $1.1B $761M $937M
EBIT $636M $973M $936M $585M $765M
 
Revenue (Reported) $4.4B $5.6B $5.8B $4.6B $5B
Operating Income (Reported) $685M $1B $936M $585M $765M
Operating Income (Adjusted) $636M $973M $936M $585M $765M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.3B $1.4B $1.4B $1.2B $1.3B
Revenue Growth (YoY) 28.04% 6.31% -1.89% -16.37% 11.32%
 
Cost of Revenues $692M $795M $738M $612M $663M
Gross Profit $655M $637M $667M $563M $645M
Gross Profit Margin 48.63% 44.48% 47.47% 47.92% 49.31%
 
R&D Expenses $140M $137M $146M $138M $151M
Selling, General & Admin $216M $251M $260M $229M $272M
Other Inc / (Exp) $1M $4M -$13M -$11M -$10M
Operating Expenses $382M $421M $432M $393M $447M
Operating Income $273M $216M $235M $170M $198M
 
Net Interest Expenses -- -- $37M $17M $23M
EBT. Incl. Unusual Items $276M $250M $185M $142M $165M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $48M $45M $35M $27M $29M
Net Income to Company $228M $205M $150M $115M $136M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $228M $205M $150M $115M $136M
 
Basic EPS (Cont. Ops) $4.26 $3.86 $2.92 $2.24 $2.64
Diluted EPS (Cont. Ops) $4.22 $3.83 $2.90 $2.23 $2.62
Weighted Average Basic Share $53.5M $53M $51.4M $51.4M $51.4M
Weighted Average Diluted Share $54M $53.4M $51.7M $51.8M $51.8M
 
EBITDA $317M $268M $266M $202M $229M
EBIT $273M $216M $222M $159M $188M
 
Revenue (Reported) $1.3B $1.4B $1.4B $1.2B $1.3B
Operating Income (Reported) $273M $216M $235M $170M $198M
Operating Income (Adjusted) $273M $216M $222M $159M $188M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $4.7B $5.7B $5.8B $4.4B $5.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.6B $3.1B $3.1B $2.3B $2.6B
Gross Profit $2.2B $2.6B $2.7B $2B $2.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $488M $564M $579M $511M $576M
Selling, General & Admin $807M $970M $991M $884M $1B
Other Inc / (Exp) -$40M -$35M -$432M -$116M -$31M
Operating Expenses $1.4B $1.7B $1.7B $1.5B $1.7B
Operating Income $802M $954M $955M $520M $793M
 
Net Interest Expenses $29M -- $44M $113M $104M
EBT. Incl. Unusual Items $733M $942M $479M $291M $658M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $90M $128M $71M $30M $109M
Net Income to Company $643M $814M $408M $261M $549M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $643M $814M $408M $261M $549M
 
Basic EPS (Cont. Ops) $12.04 $15.26 $7.92 $5.08 $10.65
Diluted EPS (Cont. Ops) $11.93 $15.14 $7.86 $5.04 $10.57
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $917M $1.1B $1.1B $697M $964M
EBIT $761M $916M $942M $522M $794M
 
Revenue (Reported) $4.7B $5.7B $5.8B $4.4B $5.1B
Operating Income (Reported) $802M $954M $955M $520M $793M
Operating Income (Adjusted) $761M $916M $942M $522M $794M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Revenue $1.3B $1.4B $1.4B $1.2B $1.3B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $692M $795M $738M $612M $663M
Gross Profit $655M $637M $667M $563M $645M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $140M $137M $146M $138M $151M
Selling, General & Admin $216M $251M $260M $229M $272M
Other Inc / (Exp) $1M $4M -$13M -$11M -$10M
Operating Expenses $382M $421M $432M $393M $447M
Operating Income $273M $216M $235M $170M $198M
 
Net Interest Expenses -- -- $37M $17M $23M
EBT. Incl. Unusual Items $276M $250M $185M $142M $165M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $48M $45M $35M $27M $29M
Net Income to Company $228M $205M $150M $115M $136M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $228M $205M $150M $115M $136M
 
Basic EPS (Cont. Ops) $4.26 $3.86 $2.92 $2.24 $2.64
Diluted EPS (Cont. Ops) $4.22 $3.83 $2.90 $2.23 $2.62
Weighted Average Basic Share $53.5M $53M $51.4M $51.4M $51.4M
Weighted Average Diluted Share $54M $53.4M $51.7M $51.8M $51.8M
 
EBITDA $317M $268M $266M $202M $229M
EBIT $273M $216M $222M $159M $188M
 
Revenue (Reported) $1.3B $1.4B $1.4B $1.2B $1.3B
Operating Income (Reported) $273M $216M $235M $170M $198M
Operating Income (Adjusted) $273M $216M $222M $159M $188M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $168M $332M $105M $137M $901M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $508M $752M $768M $521M $692M
Inventory $511M $491M $860M $804M $693M
Prepaid Expenses -- -- -- -- --
Other Current Assets $70M $106M $124M $147M $134M
Total Current Assets $1.3B $1.7B $1.9B $1.7B $2.4B
 
Property Plant And Equipment $409M $403M $434M $478M $472M
Long-Term Investments -- -- -- -- --
Goodwill $3B $3.3B $3.9B $3.9B $3.9B
Other Intangibles $402M $469M $630M $527M $422M
Other Long-Term Assets $164M $197M $276M $296M $231M
Total Assets $5.4B $6.2B $7.5B $7.3B $8B
 
Accounts Payable $601M $700M $811M $456M $633M
Accrued Expenses $354M $385M $526M $375M $237M
Current Portion Of Long-Term Debt $364M $69M $214M $173M $79M
Current Portion Of Capital Lease Obligations $30M $33M $37M $42M $36M
Other Current Liabilities $54M $15M $19M $7M --
Total Current Liabilities $1.9B $1.8B $2.3B $1.6B $1.7B
 
Long-Term Debt $881M $922M $1.8B $2B $2.1B
Capital Leases -- -- -- -- --
Total Liabilities $3.2B $3.2B $4.8B $4.3B $4.4B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$69M -$29M -$66M -$54M -$44M
Common Equity $2.1B $3B $2.7B $3B $3.6B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $2.1B $3B $2.7B $3B $3.6B
 
Total Liabilities and Equity $5.4B $6.2B $7.5B $7.3B $8B
Cash and Short Terms $168M $332M $105M $137M $901M
Total Debt $1.2B $991M $2B $2.2B $2.2B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Cash and Equivalents $177M $141M $85M $127M $879M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $521M $808M $736M $599M $617M
Inventory $528M $469M $835M $705M $681M
Prepaid Expenses -- $108M -- -- --
Other Current Assets $110M -- $140M $160M $94M
Total Current Assets $1.3B $1.6B $1.8B $1.6B $2.3B
 
Property Plant And Equipment $398M $404M $452M $470M $474M
Long-Term Investments -- -- -- -- --
Goodwill $3B $3.3B $3.9B $3.9B $3.9B
Other Intangibles $376M $437M $604M $501M $423M
Other Long-Term Assets $172M $227M $273M $312M $239M
Total Assets $5.4B $6.1B $7.5B $7.3B $7.9B
 
Accounts Payable $573M $691M $602M $467M $559M
Accrued Expenses $457M $326M $513M $285M $255M
Current Portion Of Long-Term Debt $134M $183M $215M $272M $69M
Current Portion Of Capital Lease Obligations -- $33M $36M $41M $36M
Other Current Liabilities -- $5M $24M $13M --
Total Current Liabilities $1.5B $1.8B $2.1B $1.6B $1.6B
 
Long-Term Debt $956M $913M $1.9B $1.8B $2.1B
Capital Leases -- -- -- -- --
Total Liabilities $3B $3.2B $4.6B $4.1B $4.3B
 
Common Stock $1M $1M $1M $1M $1M
Other Common Equity Adj -$40M -$29M -$66M -$50M -$65M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $2.4B $2.9B $2.9B $3.2B $3.6B
 
Total Liabilities and Equity $5.4B $6.1B $7.5B $7.3B $7.9B
Cash and Short Terms $177M $141M $85M $127M $879M
Total Debt $1.1B $1.1B $2.1B $2.1B $2.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $504M $837M $463M $296M $528M
Depreciation & Amoritzation $146M $187M $204M $176M $172M
Stock-Based Compensation $51M $76M $88M $55M $89M
Change in Accounts Receivable $130M -$239M -$5M $249M -$181M
Change in Inventories -$42M $18M -$341M $50M $105M
Cash From Operations $962M $1.1B $488M -$4M $1B
 
Capital Expenditures $67M $59M $75M $87M $59M
Cash Acquisitions -$548M -$452M -$881M -- --
Cash From Investing -$641M -$546M -$968M -$92M -$57M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $302M $46M $1.3B $440M $651M
Long-Term Debt Repaid -$342M -$303M -$247M -$245M -$694M
Repurchase of Common Stock -$200M -$57M -$751M -$52M -$47M
Other Financing Activities $83M -$57M -$33M -$26M -$100M
Cash From Financing -$157M -$371M $253M $117M -$190M
 
Beginning Cash (CF) $30M $192M $344M $117M $138M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $164M $152M -$227M $21M $766M
Ending Cash (CF) $168M $332M $105M $137M $901M
 
Levered Free Cash Flow $895M $1B $413M -$91M $954M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $228M $205M $150M $115M $136M
Depreciation & Amoritzation $44M $52M $44M $43M $41M
Stock-Based Compensation $16M $17M $18M $17M $51M
Change in Accounts Receivable -$15M -$56M $33M -$80M $84M
Change in Inventories -$17M $22M $26M $98M $15M
Cash From Operations $224M $54M -$76M $125M $178M
 
Capital Expenditures $10M $14M $16M $14M $20M
Cash Acquisitions -- -- -- -- -$62M
Cash From Investing -$23M -$19M -$17M -$11M -$82M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $130M $191M $151M --
Long-Term Debt Repaid -$156M -$25M -$119M -$284M --
Repurchase of Common Stock -- -$305M -$15M -- -$125M
Other Financing Activities -$25M -$20M $13M $9M $6M
Cash From Financing -$181M -$220M $70M -$124M -$119M
 
Beginning Cash (CF) $192M $344M $117M $138M $901M
Foreign Exchange Rate Adjustment -$2M -$2M -$1M -$1M $1M
Additions / Reductions $20M -$185M -$23M -$10M -$23M
Ending Cash (CF) $177M $141M $85M $127M $879M
 
Levered Free Cash Flow $214M $40M -$92M $111M $158M
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $643M $814M $408M $261M $549M
Depreciation & Amoritzation $156M $195M $196M $175M $170M
Stock-Based Compensation $60M $77M $89M $54M $123M
Change in Accounts Receivable $7M -$280M $84M $136M -$17M
Change in Inventories -$92M $57M -$337M $122M $22M
Cash From Operations $1.1B $899M $358M $197M $1.1B
 
Capital Expenditures $64M $63M $77M $85M $65M
Cash Acquisitions -$548M -$452M -$881M -- -$62M
Cash From Investing -$649M -$542M -$966M -$86M -$128M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $145M $176M $1.3B $400M $500M
Long-Term Debt Repaid -$462M -$172M -$341M -$410M -$410M
Repurchase of Common Stock -- -$362M -$461M -$37M -$172M
Other Financing Activities $77M -$52M -- -$30M -$103M
Cash From Financing -$240M -$410M $543M -$77M -$185M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $189M -$53M -$65M $34M $753M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $1B $836M $281M $112M $1B
Period Ending 2021-03-31 2022-03-31 2023-03-31 2024-03-31 2025-03-31
Net Income to Stockholders $228M $205M $150M $115M $136M
Depreciation & Amoritzation $44M $52M $44M $43M $41M
Stock-Based Compensation $16M $17M $18M $17M $51M
Change in Accounts Receivable -$15M -$56M $33M -$80M $84M
Change in Inventories -$17M $22M $26M $98M $15M
Cash From Operations $224M $54M -$76M $125M $178M
 
Capital Expenditures $10M $14M $16M $14M $20M
Cash Acquisitions -- -- -- -- -$62M
Cash From Investing -$23M -$19M -$17M -$11M -$82M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $130M $191M $151M --
Long-Term Debt Repaid -$156M -$25M -$119M -$284M --
Repurchase of Common Stock -- -$305M -$15M -- -$125M
Other Financing Activities -$25M -$20M $13M $9M $6M
Cash From Financing -$181M -$220M $70M -$124M -$119M
 
Beginning Cash (CF) $192M $344M $117M $138M $901M
Foreign Exchange Rate Adjustment -$2M -$2M -$1M -$1M $1M
Additions / Reductions $20M -$185M -$23M -$10M -$23M
Ending Cash (CF) $177M $141M $85M $127M $879M
 
Levered Free Cash Flow $214M $40M -$92M $111M $158M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

5 Investors to Follow Other Than Warren Buffett
5 Investors to Follow Other Than Warren Buffett

There is no doubt that Warren Buffett is one of…

Is BYD a Threat To Tesla Shareholders?
Is BYD a Threat To Tesla Shareholders?

BYD (OTC:BYDDY) has rocketed to the top of China’s booming…

CVX Vs XOM Stock, Which Energy Play Is Best?
CVX Vs XOM Stock, Which Energy Play Is Best?

Chevron (NYSE:CVX) and Exxon Mobil (NYSE:XOM) are two of the…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy
61
Is NVDA Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 40x

Alerts

Buy
60
RGC alert for May 8

Regencell Bioscience Holdings [RGC] is up 10.54% over the past day.

Buy
92
TPB alert for May 8

Turning Point Brands [TPB] is down 6.67% over the past day.

Buy
74
LIVN alert for May 8

LivaNova PLC [LIVN] is up 1.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock